BLTE ▲ +0.6% - Belite Bio, Inc $BLTE - Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1 14-OCT-2026 04:00 PM ET